Transcranial Magnetic Stimulation and Tobacco Use Disorder

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

August 19, 2024

Study Completion Date

August 19, 2024

Conditions
Tobacco Use Disorder
Interventions
DEVICE

repetitive transcranial magnetic stimulation (rTMS)

A rTMS system is an electromagnetic device that non-invasively delivers a rapidly pulsed magnetic field to the cerebral cortex in order to activate neurons within a limited volume without inducing a seizure. The device is intended to be used to treat patients meeting clinical criteria for MDD as defined in the Diagnostic and Statistical Manual of Mental Illnesses, Fourth Edition (DSM-IV). This guidance is issued in conjunction with a Federal Register notice announcing the classification of rTMS systems for the treatment of MDD.

Trial Locations (1)

90024

Semel Institute of Neuroscience, Los Angeles

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Food and Drug Administration (FDA)

FED

lead

University of California, Los Angeles

OTHER

NCT03827265 - Transcranial Magnetic Stimulation and Tobacco Use Disorder | Biotech Hunter | Biotech Hunter